Not applicableEnded earlyNCT01946100What this trial is testingTreatment of Multifocal Lung AdenocarcinomaWho this might be right forLung NeoplasmsCarcinoma Non-small-cell LungAdenocarcinoma Mayo Clinic 100
Early research (Phase 1)Looking for participantsNCT04282044What this trial is testingStudy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesWho this might be right forSolid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more BioEclipse Therapeutics 60
Not applicableLooking for participantsNCT07751783What this trial is testingDevelopment and Dissemination of Exercise Prescription and Intervention for Cancer PopulationsWho this might be right forCancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Lung Cancer (Non-Small Cell)+2 more Kaohsiung Medical University Chung-Ho Memorial Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00003666What this trial is testingIrofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 36
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Testing effectiveness (Phase 2)UnknownNCT04631731What this trial is testingRisk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityWho this might be right forLung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more Western Sydney Local Health District 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06918782What this trial is testingReal-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung AdenocarcinomaWho this might be right forLung Cancer (NSCLC) The University of Hong Kong 47
Testing effectiveness (Phase 2)Study completedNCT00818441What this trial is testingDacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The LungWho this might be right forCarcinoma, Non-small Cell Pfizer 119
Not applicableUnknownNCT03838588What this trial is testingThe Tracking Molecular Evolution for NSCLC (T-MENC) StudyWho this might be right forLung NeoplasmsLung CancerNonsmall Cell Lung Cancer+1 more Geneplus-Beijing Co. Ltd. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06922591What this trial is testingStudy to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC PatientsWho this might be right forPDACPDAC - Pancreatic Ductal AdenocarcinomaNSCLC+5 more Tango Therapeutics, Inc. 183
Very early researchEnded earlyNCT01707823What this trial is testingLow-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungRecurrent Non-small Cell Lung CancerStage IA Non-small Cell Lung Cancer+5 more Vanderbilt-Ingram Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT04027946What this trial is testingLMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung CancerNon-Small Cell Lung CancerAdenocarcinoma of Lung National Cancer Institute (NCI) 6
Early research (Phase 1)Ended earlyNCT06585488What this trial is testingA First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or AmplificationWho this might be right forMetastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more BeOne Medicines 47
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Post-approval studies (Phase 4)Study completedNCT01609543What this trial is testingTarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR MutationsWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 62
Testing effectiveness (Phase 2)UnknownNCT03402464What this trial is testingIcotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLCWho this might be right forEGFR Positive Non-Small Cell Lung Cancer,Adenocarcinoma Peking University Cancer Hospital & Institute 30
Early research (Phase 1)Looking for participantsNCT05877599What this trial is testingNT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationWho this might be right forNon-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more AstraZeneca 45
Testing effectiveness (Phase 2)Looking for participantsNCT06528847What this trial is testingAdjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung AdenocarcinomaWho this might be right forNon-Small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 62
Not applicableStudy completedNCT01836133What this trial is testingAn Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)Who this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 70